ArticleBone & joint research2026
The diagnostic accuracy of serum and synovial inflammatory markers in chronic periprosthetic joint infection among anaemic patients.
Article in Bone & joint research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Preoperative anaemia is common in patients undergoing revision total joint replacement (TJR), yet its effects on inflammatory markers for diagnosing chronic periprosthetic joint infection (PJI) are poorly understood. This study aimed to investigate how preoperative anaemia impacts inflammatory biomarkers, and to establish anaemia-adjusted diagnostic thresholds for PJI. Methods: This retrospective cohort study was conducted at a tertiary referral centre, evaluating 886 revision arthroplasty cases (396 PJI and 490 aseptic failures) between January 2008 and October 2023. Serum biomarkers (CRP, ESR, D-dimer, fibrinogen, fibrin degradation products (FDP), procalcitonin, and interleukin-6 (IL-6)) and synovial fluid markers (white blood cell count (SF-WBC) and polymorphonuclear percentage (SF-PMN)) were analyzed. The diagnostic performance of these markers was assessed using receiver operating characteristic (ROC) curve analysis, with patients stratified by anaemia status. Results: Preoperative anaemia was present in 55.1% (218/396) of patients with chronic PJI. In anaemic patients, serum biomarker levels were significantly higher than those of non-anaemic patients: CRP (28.35 vs 14.75 mg/l; p < 0.001), ESR (58 vs 40 mm/h; p < 0.001), D-dimer (615 vs 415 ng/ml; p < 0.001), and IL-6 (22.19 vs 10.74 pg/ml; p < 0.001). After adjusting diagnostic thresholds for anaemia, the area under the curve (AUC) for CRP improved from 0.838 to 0.927. Similar improvements were observed for ESR and IL-6. Fibrinogen and FDP demonstrated moderate diagnostic utility, while procalcitonin showed limited diagnostic value in both anaemic and non-anaemic patients. Conclusion: Preoperative anaemia is associated with statistically significant increases in most inflammatory biomarker levels and with higher diagnostic thresholds in chronic PJI. Anaemia-adjusted cut-off values for CRP, ESR, and IL-6 may enhance diagnostic accuracy for PJI in this patient population.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.